Evaluating Mechanisms of ADC Drug Resistance & Strategies of Rational & Orthogonal Combinations to Improve Outcomes

• Understanding the role of antigen and payload-mediated resistance mechanisms
• Laying out considerations of how cellular heterogeneity can contribute to ADC resistance
• Exploring examples of how mechanistic and orthogonal combinations can be applied towards improving ADC activity

VIRTUAL PRESENTATION

Speakers:

Emily Mason-Osann

Associate Principal Scientist, In Vivo Bioscience

AstraZeneca